Dr. Yuzpe has been the recipient of numerous awards, including the Canadian Fertility and Andrology Society Award of Excellence in Reproductive Medicine, the Society of Obstetricians and Gynecologists Presidents Award ("for his distinguished career in academic reproductive endocrinology and infertility and his dedication to women's health in Canada and abroad"), and the Royal College of Physicians and Surgeons Speaker's Award.
Dr. Yuzpe is co-founder and co-director of Olive Fertility Centre. As Canada's most senior Reproductive Endocrinologist, he has been involved in IVF for the past 30 years and in the field of infertility for the past 43 years.
He received his MD, M Sc. and completed his fellowship training in obstetrics and gynecology at Western University, London, Ontario. During his training, Dr. Yuzpe was a Fellow of the Medical Research Council of Canada for two years with his research focusing on the development and refinement of fertility-promoting drugs, including clomiphene and human gonadotropins.
Dr. Yuzpe joined the Western University Faculty of Medicine, Department of Obstetrics and Gynecology, in 1970 and passed through the academic ranks to full professor. He retired from the university in June, 1995, and now holds the distinguished academic appointment of Emeritus Professor of Obstetrics and Gynecology. Dr. Yuzpe then went on to found the Genesis Fertility Centre in Vancouver, British Columbia.
He pioneered the development of the emergency contraceptive pill, which is often referred to as "The Yuzpe method." This method was recently listed by the Canadian Child and Youth Health Coalition as among the 10 Canadian discoveries with the greatest impact, or the greatest potential for impact, on health outcomes for children and youth in the last 100 years.
Baerwald A, Anderson P, Yuzpe A, Case A, Fluker M,Synchronization of Ovarian Stimulation with Follicle Wave Emergence in Patients Undergoing In Vitro Fertilization with a Prior Suboptimal Response: a Randomized, Controlled Trial. Fertil Steril, October 2012 98(4):881-7.e1-2. doi: 10.1016/j.fertnstert.2012.06.051. Epub 2012 Jul 20
Bushnik T, Cook JL, Yuzpe AA, Tough S, Collins J,Estimating the Prevalence of Infertility in Canada. Hum Reprod, March 2012 27(3):738-46. doi: 10.1093/humrep/der465. Epub 2012 Jan 17. Erratum in: Hum Reprod. 2013 Apr;28(4):1151
Bissonnette F, Cohen J, Collins J, Cowan L, Dale S, Dill S, Greene C, Gysler M, Hanck B, Hughes E, Leader A, McDonald S, Marrin M, Martin R, Min J, Mortimer D, Mortimer S, Smith J, Tsang B, van Vugt D, Yuzpe A;Canadian Fertility and Andrology Society, Incidence and Complications of Multiple Gestation in Canada: Proceedings of an Expert Meeting. Reprod Biomed Online, June 2007 14(6):773-90
Tan SL, Child TJ, Cheung AP, Fluker MR, Yuzpe A, Casper R, Leung P, Cadesky K, Davis VJ,A Randomized, Double-Blind, Multicenter Study Comparing a Starting Dose of 100 IU or 200 IU of Recombinant Follicle Stimulating Hormone (Puregon) in Women Undergoing Controlled Ovarian Hyperstimulation for IVF Treatment. J Assist Reprod Genet, February 2005 22(2):81-8
Inclusion of all gender and sexually diverse people is an important value of Olive Fertility Centre. We are continuously striving to create an environment of compassionate belonging where all of the 2SLGBTQIA+ community are supported, valued and respected.
Olive Fertility Centre resides on the traditional, ancestral, and unceded territory of the xʷməθkwəy̓əm (Musqueam), Skwxwú7mesh (Squamish), and Tsleil-waututh Nations (Vancouver and Surrey clinics), of the Lekwungen people (Victoria clinic), of the syilx/Okanagan people (Kelowna clinic) and of the Lheidli T’enneh First Nation (Blossom Fertility clinic in Prince George).
© 2022-2023 Olive Fertility Centre. All Rights Reserved.